20.03.2018 - 22.03.2018Hilton London Olympia, 380 Kensington High Street, Kensington, W14 8NL London, Großbritannien
Time: 9:00 am to 4:00 pm
Kongressthemen The Complement-based Drug Development Summit Europe is the first industry-dedicated meeting focused on optimizing clinical trial design, efficacy assessment, target identification and expansion beyond orphan diseases.
Across 3 content-packed days, the field's thought leaders from GSK, Novartis, Complement Pharma and many more will be sharing their insight and lessons learned, collectively enabling the community to.
Kongressorganizer (PCO) Hanson Wade Ltd.
Anmerkungen Speakers: Anna Schubart (Novartis), Andrea Tenner (University of California), Michael Holers (University of Colorado), Paul Morgan (Cardiff University), Eva-Maria Nichols (GlaxoSmithKline), Michael Kirschfink (University of Heidelberg)